Evidence map›Paper›PMID 21868368›Full record

ArticleJournal of cell science2011

Dynamic remodeling of the actin cytoskeleton by FMNL1γ is required for structural maintenance of the Golgi complex.

Jessica M Colón-Franco, Timothy S Gomez, Daniel D Billadeau

Abstract read
In one paragraph

Article in Journal of cell science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jessica M Colón-FrancoDepartment of Biochemistry and Molecular Biology, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55901, USA.
Timothy S Gomez
Daniel D Billadeau
Mayo Clinic · US

Funding

MECHANISMS OF NATURAL KILLER CELL ACTIVATIONR01CA047752 · NCI · MAYO CLINIC ROCHESTER · PI BILLADEAU, DANIEL D · 1990 to 2012
$3.8M
Regulation of Actin Dynamics During T Cell ActivationR01AI065474 · NIAID · MAYO CLINIC ROCHESTER · PI BILLADEAU, DANIEL D · 2005 to 2014
$3.1M
TRAINING PROGRAM IN ALLERGIC DISEASEST32AI007047 · NIAID · MAYO CLINIC ROCHESTER · PI KITA, HIROHITO · 1985 to 2016
$2.0M
NCI NIH HHS R01 CA047752NCI NIH HHS R01-CA47752NIAID NIH HHS R01 AI065474NIAID NIH HHS R01-AI065474NIAID NIH HHS T32 AI007047NIAID NIH HHS T32-AI07047
6 · The paper itself

Abstract

Formin-like 1 (FMNL1) is a member of the formin family of actin nucleators, and is one of the few formins for which in vitro activities have been well characterized. However, the functional roles of this mammalian formin remain ill-defined. In particular, it is unclear how the unique in vitro biochemical properties of FMNL1 relate to its regulation of cellular processes. Here, we demonstrate that FMNL1 depletion caused a dramatic increase in cellular F-actin content, which resulted in Golgi complex fragmentation. Moreover, increased F-actin and maintenance of Golgi structure were distinctly regulated by the gamma isoform of FMNL1, which required binding to actin. Importantly, in addition to Golgi fragmentation, increased F-actin content in the absence of FMNL1 also led to cation-independent mannose 6-phosphate receptor dispersal, lysosomal enlargement and missorting of cathepsin D. Taken together, our data support a model in which FMNL1 regulates cellular F-actin levels required to maintain structural integrity of the Golgi complex and lysosomes.

Indexed as

ActinsCathepsin DCytoskeletal ProteinsCytoskeletonForminsGolgi ApparatusHeLa CellsHomeostasisHumansJurkat CellsLysosomesMolecular StructureProtein BindingProtein IsoformsProtein TransportReceptor, IGF Type 2ActinsCathepsin DCytoskeletal ProteinsFMNL1 protein, humanForminsProtein IsoformsReceptor, IGF Type 2RNA, Small Interfering

Identifiers

PMID21868368
PMCPMC3172187
OpenAlexW2164894696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.